Improving risk‐stratification of natalizumab‐associated PML

Based on publicly available data, we reevaluated current algorithms for stratifying the risk of progressive multifocal leukoencephalopathy (PML) in natalizumab‐treated patients with multiple sclerosis, and found that there are a number of issues. First and foremost, our analysis highlights the neces...

Descripción completa

Detalles Bibliográficos
Autores principales: Tugemann, Bastian, Berger, Joseph R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Brief Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7951098/
https://www.ncbi.nlm.nih.gov/pubmed/33539683
http://dx.doi.org/10.1002/acn3.51130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7951098/
https://www.ncbi.nlm.nih.gov/pubmed/33539683
http://dx.doi.org/10.1002/acn3.51130

Ejemplares similares